Staff Editor
Verve Therapeutics halted its "Heart-1" gene-editing trial after undisclosed side effects arose, following the death of a...
Staff Editor
An equity incentive plan serves to involve employees in the company's success and encourage retention, yet many...
Kaikaku, a startup specializing in automated robotics for restaurants, has recently secured $1.8 million in funding and...
Millions of eager spectators across North America anticipated Monday's total solar eclipse, despite cloudy forecasts. The best...
In Oregon, a lucky Powerball player ended a three-month dry spell by winning a staggering $1.3 billion...
Chinese scientist He Jiankui made headlines in 2018 for using CRISPR to edit human embryos, resulting in...
Entrepreneurship can seem daunting when we lack knowledge, but spending time with entrepreneurs can change our perspective....
Mark Zuckerberg's vast real estate empire, valued around $200 million, is shrouded in secrecy with the use...
The U.S. Food and Drug Administration's accelerated approval program aims to provide early access to promising drugs...
A lawsuit filed in Los Angeles Superior Court names Sean "Diddy" Combs as a co-defendant, alleging that...
